Use access key #2 to skip to page content.
$2.10 0.00 (0.00%)
5/2/2008 4:00 PM

Renovis, Inc. (RNVS)

CAPS Rating:
*

The Company is a science-driven, biopharmaceutical company that seeks to discover, develop, and commercialize therapeutics for major medical needs in the areas of neurological and inflammatory diseases.

View All Commentary (RNVS)

Recs

0

Avatar tonzerone (39.70) Submitted: 10/26/06 1:16 PM : Outperform Start Price: $3.81 RNVS Score: -8.61

down 75% today, at cash value, will rebound

Report this Post Replies: 0 | Reply

Featured Broker Partners